Published on Apr 11, 2019
Published on Apr 11, 2019
A Freedom of Information Act (FOIA) request results in the release of trial results of MMR vaccines that show a shocking percentage of children participating in the study suffering from gastrointestinal illness and upper-respiratory illness after receiving the Measles, Mumps & Rubella shot.
For the full HIGHWIRE episode with Del Bigtree click HERE
By Full Measure Staff
Full Measure is a weekly Sunday news program focusing on investigative, original and accountability reporting. The host is Sharyl Attkisson, five-time Emmy Award winner and recipient of the Edward R. Murrow award for investigative reporting. She is backed by a team of award winning journalists.
Each week, we have a cover story that explores untouchable topics in a fearless way including: immigration, terrorism, government waste, national security and whistleblower reports on government and corporate abuse and misdeeds.
Full Measure is broadcast to 43 million households in 79 markets on 162 Sinclair Broadcast Group stations, including ABC, CBS, NBC, FOX, CW, MyTV, Univision and Telemundo affiliates. It also streams live Sunday mornings at 9:30 a.m. ET.
http://fullmeasure.news/
POSTED BY: CHILDREN’S HEALTH DEFENSE
Using data collected from parents of more than 43,000 children from the 2016 HRSA National Survey of Children’s Health, researchers are now estimating as many as 1 in 40 children ages 3 to 17 in the U.S. have been diagnosed with autism. This is a huge increase from April 2018 when the CDC reported 1 in 59 children are on the spectrum.
Published online in the journal Pediatrics, the new HRSA study looked at a wider age range of children and used data collected from parents nationally vs. the CDC’s more narrow review of medical and school records of 8-year-olds living in 11 residential areas.
This article from UPI provides additional insights from the researchers and more specific details about the results.
Celeste McGovern on Nov 19, 2018 1:32:03 PM
CHILDREN’S MEDICAL SAFETY RESEARCH INSTITUTE
Aluminum salts, a key ingredient added in growing amounts to numerous childhood and adult vaccines, have never been tested for their effects on health in humans, a new review paper from British researchers says.
“Aluminum based adjuvants are effective and cheap but are they safe?” the team of researchers at Keele University ask in the study published this month in Allergy, Asthma & Clinical Immunology.
Although aluminum has been used for decades as an adjuvant to provoke the immune system to make antibodies to other vaccine ingredients, it works precisely because it is toxic, said Christopher Exley, who has studied the metal’s adverse effects biological systems from fish to humans for more than three decades. His paper with Emma Shardlow and Matthew Mold reviews what is known about the different modes of action of different aluminum salts and confirms that it may account for the wide spectrum of serious adverse events associated with vaccines.
“Aluminium-adjuvanted vaccines have a long history of clinical successes and a commensurately long history of vaccine-related adverse events,” the scientists write. “Since there is no requirement to demonstrate the safety of [aluminum-based adjuvants] ABAs, one could quickly surmise that adverse events following vaccination are the direct or indirect effects of ABAs.”
“What might be the cause of such events, ranging from health issues directly associated with the injection site to brain encephalopathy and death?” Exley asks in a related blog published today in the Hippocratic Post.
“We know that aluminium adjuvants are toxic at the injection site, this toxicity is essentially their mode of action (see https://www.hippocraticpost.com/infection-disease/aluminium-adjuvants-vaccines/), and evidence is burgeoning that this toxicity is also being manifested away from the injection site (see https://www.hippocraticpost.com/infection-disease/aluminium-and-autism/).”
No placebos
Taking aim at pharmaceutical giant Merck, the manufacturer of Gardasil and Gardasil 9 vaccines against the human papilloma virus (HPV), Exley notes that the company has “prevented any independent study of its proprietary adjuvant and concomitantly this vaccine has arguably the highest frequency of recorded adverse events of all vaccines and this according to the manufacturer’s own data!”